Asklepios BioPharmaceutical, Inc. (AskBio)

The #AskBio team recently left Rome, Italy and the 2024 European Society of Gene & Cell Therapy Congress, where we appreciated having the opportunity to engage in broad scientific exchange on a range of gene therapy topics, covering our pre-clinical, clinical, and manufacturing activities. We met hundreds of people who share our passion for advancing science and technology to create meaningful impacts for people living with debilitating conditions, including Parkinson's disease. A leading highlight was the oral presentation from Krystof Bankiewicz and moderated by Nathalie Cartier Lacave, which provided an update on the clinical progress and upcoming plans for AB-1005, our investigational Parkinson’s gene therapy. Big thanks to every member of our on-site team for leading our activities and to the attendees who engaged us in conversations and expressed significant interest in learning more about our current and future work. #GeneTherapy #ParkinsonsDisease #ESGCT

#AskBio employees are on a mission to lead innovative science. For Di Ana Zhang, a scientist with the Nanoplatform Discovery R&D team, this aligns with being a pioneer, which is one of our core values. Specifically, for Di Ana, this means not being afraid of what some may consider impossible and innovating to make gene therapies accessible to those in need. In addition, Di Ana has a strong sense of purpose knowing that her efforts and those of her colleagues may contribute to improving health and quality of life. This awareness helps inspire a commitment to excellence, driving innovation, and fostering a collaborative spirit, as each R&D achievement has the potential to make a significant difference in real lives. Interested in helping us make a difference? Visit https://lnkd.in/ejPBtp8 to explore opportunities in hashtag #GeneTherapy. Let’s make history together.

Two days in and two days to go at the 2024 European Society of Gene & Cell Therapy Congress. The #AskBio team is feeling energized as we meet with scientists from around the world to discuss the collective progress across the field of #GeneTherapy. We are inspired by the work happening, and are particularly proud of efforts to progress our clinical and pre-clinical pipeline and advance our manufacturing technologies. We've completed 10 of our 11 presentations and look forward to our final oral presentation on Thursday, October 24, 9:00-11:00 local time (Session 7d: CNS Gene Therapy, Auditorium PARALLEL): Clinical Progress and Plans for AB-1005 (AAV2GDNF) Gene Therapy for Parkinson's Disease. The presentation will be delivered by Krystof Bankiewicz, MD, PhD, Scientific Chair, Parkinson’s and MSA, AskBio and co-chaired by Nathalie Cartier Lacave, MD, Senior Vice President, Sector Lead, Neurobiology, AskBio. Visit us at booth D19 to learn more about all we are doing. #Leadership #ESGCT2024 Danielle Green, Meg Heim, Krishen Somers, Roger Hajjar, Scott Hammond, Amber Van Laar, Madhuvanthi Vijayan Ph.D., Krystof Bankiewicz, Marco Zahn, Kathleen Boerner, Emma Smith, PhD, Micol Alberti, Rachael Di Santo; Graham W., Enejda Subashi, Sandro Alves, Nathalie Cartier Lacave, Ralph Herbst, Christian Blaszkewicz, Eva-Maria Wicklein, Kristian Johnson, Karen Bulaklak, Ph.D., Juan Enrique Ortiz, M.D. BCMAS

We're excited to be in Rome, Italy, from October 22 to 25, for this year's European Society of Gene & Cell Therapy Congress. The #AskBio team will deliver 11 presentations, including two orals, as well as meet with physicians and others to discuss the exciting progress taking place in our clinical and pre-clinical pipeline and advancements in our manufacturing technologies. Visit us at booth D19. #Leadership #GeneTherapy #ESGCT2024 Kristian Johnson; Madhuvanthi Vijayan Ph.D.; Danielle Green; Graham W.; Scott Hammond; Karen Bulaklak, Ph.D.; Juan Enrique Ortiz, M.D. BCMAS; Rachael Di Santo; @Eva-Maria Wicklein

We are thrilled to be in Rome, Italy, next week to deliver 11 presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting. The two oral and nine poster presentations highlight exciting progress in the #AskBio clinical and pre-clinical pipeline and advancements in our manufacturing technologies. Alongside recent clinical program milestones, the presentations demonstrate our commitment to advancing our end-to-end capabilities and our goal of delivering breakthrough therapies. For Medical Media – Read our press release here: https://lnkd.in/esFnVFcs #GeneTherapy #ESGCT2024 

Today is World Mental Health Day, a day aimed at raising awareness about the importance of mental health and well-being in our lives, both professionally and personally. This year's theme is focused on prioritizing mental health in the workplace. The #AskBio employee assistance program and our flexible paid time off benefits help provide our employees with resources and tools to support their well-being.     In addition to our more formal support, we encourage colleagues to form employee resource groups (ERGs), which add to our vibrant workplace culture by sponsoring events, providing information/education, and engaging in important conversations. On this important day, we’re proud to announce that we’re expanding our ERG network with our newest group, Minds of All Kinds. Co-founded by James Aykit and Amanda Carson. This ERG's mission is to empower those with neurodivergent, intellectual, and mental health differences by providing a safe space for learning, feedback, coaching, and education.   Minds of All Kinds was created based on feedback from and the success of our Disability Pride event in July. We believe that when we can provide an inclusive environment for employees to reach their fullest potential, we are best suited to lead innovative science and drive clinical outcomes, which may transform people's lives.    #MentalHealthMatters #WellbeingAtWork #WorldMentalHealthDay #Leadership #GeneTherapy

More than 50 #AskBio employees in the US and Europe recently participated in the Path to A Cure: Mission MSA Virtual Walk to support patients and families affected by multiple system atrophy (MSA).    Our collective participation helped spread awareness to better understand and support people battling this complex disease. Patients are our North Star, and their resilience continues to be an inspiration for our mission of leading innovative science and driving clinical outcomes that may transform people's lives. Thanks to Mission MSA for providing us with this opportunity to come together as a team, across locations and time zones, and play a small role in helping them carry out their important work.   #MissionMSA #PathToACure5K #RareDisease #WorldMSADay #GeneTherapy   Alan Walsh ACA; Albana Alili Dalipi; Anand Thaker; Candace Summerford, Ph.D.; Cara Davis; Christopher Allen; Danielle Green; Deb Cole, CCDM; Ellen Kelly; Emily Slocum; Farah CHALI; Heather Caro, MBA BSN; Jane Williamson; Jason Krentz; Jen Barger Fleming, PhD DABT; Jenny Siferd, SPHR; Kara Witcoff; Mary Shaffer; Melissa Murrell; Minnal Gupta; Philip McNamara; Rosheen Caw; Susan Kratky; Tracy Dowling; Victor Stukat Gren; Kavonne Brooks; Gustavo Pesquin

The #AskBio team earlier this week wrapped up five days in Philadelphia, PA, at this year's International Congress of Parkinson's Disease and Movement Disorders. Thank you to the hundreds of attendees who visited our booth, attended our presentations, and took time to discuss with us the many exciting gene therapy developments that are unfolding at AskBio and across the Parkinson's disease landscape.     A leading highlight was the presentation of our 36-month Phase 1b Parkinson’s investigational clinical trial data, which demonstrate encouraging current clinical stability of AB-1005 at 3 years. We look forward to continued follow up, which will help assess even longer term durability. We were also excited to present the design of our currently recruiting Phase 2 REGENERATE-PD trial. Fielding dozens of questions at our booth, we were energized by the significant interest in learning more about gene therapy. To learn more about these clinical trials, please visit clinicaltrials.gov (NCT 04167540 and NCT 06285643).   We are excited about the potential of our advancing investigational gene therapy therapeutic options and by the meaningful impact our innovations could one day have for PD patients. Thanks to all the members of the AskBio team for their hard work over a busy and important few days. #Leadership #GeneTherapy #ParkinsonsDisease Adrian Kells, Akash P., Amber Van Laar, Chantal Letourneau, Christian Urrea, MD, Ellie (Yiqun) Hu), Juan Enrique Ortiz, M.D. BCMAS, Nisha Chhabria MD, FAAN, Steven Elmes, Waldy San Sebastian

We're excited to welcome Cristobal Passalacqua, MD who recently joined the #AskBio Global Clinical Development team as Vice President of Neuromuscular Clinical Development. Chris will be responsible for developing limb-girdle muscular dystrophy (LGMD) and Pompe studies as we work to advance these programs in the clinic. He describes himself as an optimist who believes there is always a solution or at least a positive way to deal with a situation. This mantra has supported Chris throughout his career in clinical development, where every day there are new challenges that may seem “too big” or “too complicated” to solve. #Leadership #GeneTherapy

We’re passionate about supporting the communities we serve and are excited to join Mission MSA’s Virtual Path to a Cure 5K. This is a special event for all of us at #AskBio...for a few reasons. First, as a company committed to exploring the potential of gene therapy in #MSA, we are grateful to have the opportunity to support an amazing organization and help raise awareness. Second, with our multiple locations in the US and Europe, and a large number of remote employees, we’re experts at coming together virtually to do important things, but it’s sometimes difficult for all of us to come together at one time as a global team and pursue fun and meaningful activities outside of work. #PathtoaCure5K gives us that chance. We’re looking forward to sharing photos next week of our colleagues as they put in their steps over the next few days and walk alongside every member of the MSA community. Melissa Murrell, Jen Barger Fleming, PhD DABT, Susan Kratky, Kara Witcoff, Meg Heim, Tara Swann, Victor Stukat Gren, Anand Mirchandani, Anand Thaker, Cristina Gude, Cara Davis, Ellen Kelly, Heather S., Albana Alili Dalipi, Danielle Green, Caitlin Taroski, Bishoy A., Sarah Smith, Katie Morris, Rosheen Caw, Vosha A., Stacy Ojala, Emily Slocum, Tracy Dowling, Kavonne Brooks, Heather Caro, MBA BSN, Trish Hamilton, Matt Fortier, Deb Cole, CCDM, Jenny Siferd, SPHR, Philip McNamara